These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 8980655
1. Increased autocrine production of insulin-like growth factor II (IGF-II) alters serum sensitivity of MCF-7 human breast cancer cell proliferation. Corcoran D, Perachiotti A, Darbre PD. Cell Prolif; 1996 Sep; 29(9):479-93. PubMed ID: 8980655 [Abstract] [Full Text] [Related]
3. Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression. Abdul-Wahab K, Corcoran D, Perachiotti A, Darbre PD. Cell Prolif; 1999 Oct; 32(5):271-87. PubMed ID: 10619489 [Abstract] [Full Text] [Related]
4. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH. Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302 [Abstract] [Full Text] [Related]
5. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ. Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657 [Abstract] [Full Text] [Related]
6. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. McGuire WL, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D. J Natl Cancer Inst; 1992 Sep 02; 84(17):1336-41. PubMed ID: 1379645 [Abstract] [Full Text] [Related]
7. Insulin-like growth factor-I and its autocrine role in growth of MCF-7 human breast cancer cells in culture. Freed KA, Herington AC. J Mol Endocrinol; 1989 Nov 02; 3(3):183-90. PubMed ID: 2590382 [Abstract] [Full Text] [Related]
8. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwiebel JA. Mol Endocrinol; 1992 Jan 02; 6(1):91-100. PubMed ID: 1310798 [Abstract] [Full Text] [Related]
9. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. Han VK, Bassett N, Walton J, Challis JR. J Clin Endocrinol Metab; 1996 Jul 02; 81(7):2680-93. PubMed ID: 8675597 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT, Fontana JA. J Cell Physiol; 1994 Jan 02; 158(1):69-78. PubMed ID: 7505280 [Abstract] [Full Text] [Related]
14. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Rozen F, Zhang J, Pollak M. Int J Oncol; 1998 Oct 02; 13(4):865-9. PubMed ID: 9735418 [Abstract] [Full Text] [Related]
15. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue. Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K. Breast Cancer Res Treat; 2006 Oct 02; 99(3):275-88. PubMed ID: 16752221 [Abstract] [Full Text] [Related]
16. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Slootweg MC, Ohlsson C, Salles JP, de Vries CP, Netelenbos JC. Endocrinology; 1995 Oct 02; 136(10):4210-7. PubMed ID: 7545101 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor II mRNA expression in human breast cancer. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N. Cancer Res; 1988 Dec 01; 48(23):6691-6. PubMed ID: 3180080 [Abstract] [Full Text] [Related]
20. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II. Singh P, Dai B, Yallampalli U, Lu X, Schroy PC. Endocrinology; 1996 May 01; 137(5):1764-74. PubMed ID: 8612513 [Abstract] [Full Text] [Related] Page: [Next] [New Search]